Portrait of Scott Shively

Scott Shively

President & CEO, Bexion Pharmaceuticals

Scott Shively is an experienced Founder, CEO and CCO in the US and international biopharma markets. He is currently President & CEO of Bexion Pharmaceuticals, a clinical development stage biotech company developing a novel first-in class biologic for solid tumor cancers and Chemotherapy Induced Peripheral Neuropathy.  He previously served as CEO and Co-founder of Neumentum, Inc., a private clinical development stage company focused in the Pain and CNS therapeutic areas. His career spans from leading global commercial efforts for Pfizer in the Pain and CNS areas to C-suite leadership roles in specialty growth companies such as Alpharma, Zogenix and Depomed. Scott has extensive experience in product commercialization and launch, building and leading multifunctional teams, M&As and business development and fundraising, and has been involved in successful exits for several small to mid-sized biopharma companies.